Learn about a new topic and earn 1 P.A.C.E.® credit per webinar. All upcoming webinars are free for ASCLS members ($10 for nonmembers or customers). If you can’t attend live, register anyway—those who pre-register will receive access to the webinar recording.December 10, 12 pm ET
Optimizing Liver Function Test Interpretation in NAFLD: Transaminases, Uric Acid, and the Critical Role of Provider Education
Presenter:Mark Kellogg, PhD, MLS(ASCP), DABCC, Associate Director of Chemistry at Boston Children’s Hospital
Description: This presentation examines the complexities of liver function test interpretation in non-alcoholic fatty liver disease (NAFLD), with emphasis on understanding transaminase reference intervals and the emerging role of uric acid as a biomarker. The session addresses a critical gap in clinical practice: up to 86 percent of NAFLD patients may present with normal ALT levels, yet many providers rely solely on traditional reference ranges for screening and monitoring. Through case-based discussion and evidence review, participants will learn practical strategies for accurate test interpretation and how targeted provider education can improve early detection and management of NAFLD.
Objectives:
-
Evaluate the clinical significance of serum uric acid levels as an independent risk factor for NAFLD development and progression, understanding the 2.1-fold increased odds associated with hyperuricemia.
-
Apply evidence-based strategies for monitoring patients with NAFLD using appropriate intervals for liver enzyme reassessment, fibrosis scoring, and specialist referral criteria.
-
Implement provider education interventions that address common misinterpretations of liver function tests and promote guideline-concordant care for NAFLD patients.
Instruction Level: Intermediate
Registration: Free for ASCLS members; $10 for non-members
A list of previous webinars can be found on ASCLS Labucate under Past Live Events.